ResearcherHenan UniversityNo recent work listed

Yuanyuan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8462-2637; OpenAlex author ID A5100320622. Sources: OpenAlex.

Their work

Papers: 4 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 9

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers

Papers 4

Retraction notice to "Long non-coding RNA HULC promotes proliferation, migration and invasion of pancreatic cancer cells by down-regulating microRNA-15a" [Int.… Last author DOI 10.1016/j.ijbiomac.2022.02.050 ↗
Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2021.101317 ↗
Long non-coding RNA HULC promotes proliferation, migration and invasion of pancreatic cancer cells by down-regulating microRNA-15a. Last author DOI 10.1016/j.ijbiomac.2018.12.238 ↗
MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1. Co-author DOI 10.1007/s13277-016-5445-8 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Haomiao Feng · 2 shared papers, 2019–2022 · strength 0.42
- Paper Retraction notice to "Long non-coding RNA HULC promotes proliferation, migration and invasion of pancreatic cancer cell… DOI 10.1016/j.ijbiomac.2022.02.050 ↗
- Paper Long non-coding RNA HULC promotes proliferation, migration and invasion of pancreatic cancer cells by down-regulating m… DOI 10.1016/j.ijbiomac.2018.12.238 ↗
Xiaona Fan · 1 shared paper, 2022 · strength 0.16
- Paper Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal… DOI 10.1016/j.tranon.2021.101317 ↗
Yang Ge · 1 shared paper, 2022 · strength 0.16
- Paper Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal… DOI 10.1016/j.tranon.2021.101317 ↗
Rui Yan · 1 shared paper, 2022 · strength 0.16
- Paper Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal… DOI 10.1016/j.tranon.2021.101317 ↗
Guangyu An · 1 shared paper, 2022 · strength 0.16
- Paper Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal… DOI 10.1016/j.tranon.2021.101317 ↗
Xueju Wei · 1 shared paper, 2016 · strength 0.05
- Paper MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1. DOI 10.1007/s13277-016-5445-8 ↗
Lijun Zhao · 1 shared paper, 2016 · strength 0.05
- Paper MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1. DOI 10.1007/s13277-016-5445-8 ↗
Guotao Sun · 1 shared paper, 2016 · strength 0.05
- Paper MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1. DOI 10.1007/s13277-016-5445-8 ↗
Jia Yu · 1 shared paper, 2016 · strength 0.05
- Paper MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1. DOI 10.1007/s13277-016-5445-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.